PFM Health Sciences’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
PFM Health Sciences's BLTE Position: Q3 2026 in Review
PFM Health Sciences increased its Belite Bio (BLTE) stake by 58% in Q3 2026, buying an estimated $3.29M and bringing the position to 55,078 shares worth $9.35M. The position accounts for 0.93% of the portfolio, ranked #43.
PFM Health Sciences first reported a position in BLTE in Q4 2025 and has held it in 4 quarters since. The position peaked at $9.48M in Q1 2026. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- PFM Health Sciences held 55,078 shares of Belite Bio worth $9.35M as of Q3 2026.
- PFM Health Sciences bought 20,275 Belite Bio shares in Q3 2026, an estimated $3.29M.
- Belite Bio made up 0.93% of PFM Health Sciences's portfolio in Q3 2026, its #43 holding.
- PFM Health Sciences first reported a position in Belite Bio in Q4 2025 and has held it in 4 quarters since.
- PFM Health Sciences's Belite Bio position peaked at $9.48M in Q1 2026.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on PFM Health Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.